ERBB2 and breast cancer: The correlation of DMAP1 and molecular typing markers for breast cancer showed that DMAP1 expression was lower in ER negative (Figure 4D), PR negative (Figure 4E), and HER2 positive subtypes (Figure 4F), as well as in tumors with high Ki67 expressed (Figure 4G).